Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.

ABSTRACT

AIMS/HYPOTHESIS: Diabetes has been identified as a risk factor for poor prognosis of coronavirus disease-2019 (COVID-19). The aim of this study is to identify high-risk phenotypes of diabetes associated with COVID-19 severity and death. METHODS: This is the first edition of a living systematic review and meta-analysis on observational studies investigating phenotypes in individuals with diabetes and COVID-19-related death and severity. Four different databases were searched up to 10 October 2020. We used a random effects meta-analysis to calculate summary relative risks (SRR) with 95% CI. The certainty of evidence was evaluated by the GRADE tool. RESULTS: A total of 22 articles, including 17,687 individuals, met our inclusion criteria. For COVID-19-related death among individuals with diabetes and COVID-19, there was high to moderate certainty of evidence for associations (SRR [95% CI]) between male sex (1.28 [1.02, 1.61], n = 10 studies), older age (>65 years 3.49 [1.82, 6.69], n = 6 studies), pre-existing comorbidities (cardiovascular disease 1.56 [1.09, 2.24], n = 8 studies; chronic kidney disease 1.93 [1.28, 2.90], n = 6 studies; chronic obstructive pulmonary disease 1.40 [1.21, 1.62], n = 5 studies), diabetes treatment (insulin use 1.75 [1.01, 3.03], n = 5 studies; metformin use 0.50 [0.28, 0.90], n = 4 studies) and blood glucose at admission (≥11 mmol/l 8.60 [2.25, 32.83], n = 2 studies). Similar, but generally weaker and less precise associations were observed between risk phenotypes of diabetes and severity of COVID-19. CONCLUSIONS/INTERPRETATION: Individuals with a more severe course of diabetes have a poorer prognosis of COVID-19 compared with individuals with a milder course of disease. To further strengthen the evidence, more studies on this topic that account for potential confounders are warranted. REGISTRATION PROSPERO registration ID CRD42020193692.